Italy’s innovation output in 2025, as recorded by the Italian Patent & Trademark Office (UIBM), reflects not only commercial activity but the practical operation of a specific legal architecture: the Italian Code of Industrial Property (CPI), the EU Unitary Patent framework, and the fiscal and public-funding instruments that support research commercialisation.
Filing activity at the Italian Patent Office
The UIBM received 14,321 national patent applications in 2025: 11,996 for industrial inventions under Article 45 CPI and 2,073 for utility models under Article 82 CPI. Industrial invention filings rose approximately 18% year on year, the highest volume recorded in fifteen years; utility model filings rose 13.2%.
A significant portion of this growth is attributable to a specific statutory reform. Article 65 CPI, which formerly vested ownership of academic inventions in the individual researcher (the so-called ‘professor’s privilege’), was amended to centralise title in the university or public research body itself. Filings by universities and public research bodies rose to 594 applications, an increase of roughly a fifth on 2024. This is a direct illustration of how a change to statutory ownership rules can alter filing behaviour without any change in underlying inventive activity. The UIBM also credits the growth to the institutional strengthening of Office of Technical Transfer (Uffici di Trasferimento Tecnologico), the offices responsible for managing technology transfer on behalf of the titleholder institutions.
Territorial distribution of patent filings, concentrated in Lombardy, Piedmont, Veneto, Emilia-Romagna, and Lazio, is a matter of fact rather than law, but it is relevant to any assessment of where enforcement activity and licensing negotiations are most likely to originate.
The Unitary Patent and the Decline in national validations
A proper reading of the 2025 figures requires distinguishing between national title creation and the separate regime governing European patents. Requests to validate a European patent in Italy fell by 13% in 2025. This is not evidence of reduced patent activity; it reflects the operation of Regulation (EU) No 1257/2012 and the entry into force, since 2023, of the European patent with unitary effect, under which protection automatically extends to Italy as a participating Member State without a national validation procedure before the UIBM. By 31 December 2025 the EPO had granted 78,707 unitary patents, of which 5,290 originated from Italian applicants, a figure that places Italy fifth by applicant origin globally and third within the EU. Total UIBM deposits accordingly fell by roughly 2%, an outcome fully explained by this jurisdictional shift rather than by any reduction in underlying protection-seeking behaviour.
Grant Rates and the Interval between Filing and Grant
The UIBM granted 8,577 titles in 2025, a decrease of approximately 5% on 2024. This should not be read as a contraction in patentability outcomes. Grant figures in any given year reflect the prosecution of applications filed in prior periods, given the statutory examination timeline under the CPI; a decline in grants in a year of record filings is consistent with, rather than contrary to, the underlying growth trend.
Italian Public Funding Instruments Supporting the Ecosystem
The statutory reform to Article 65 CPI did not operate in isolation. It sits alongside a wider set of public instruments, including CDP Venture Capital, the Startup Act (Decree-Law No. 179/2012, as subsequently amended), R&D tax credit regimes, and the more recent ScaleUp Act, all of which are designed to convert protected inventions into commercially exploited assets. Independent data from the Global Startup Ecosystem Index 2025 indicates that Italy ranks 28th globally for startup ecosystem strength, with total funding exceeding $1.5 billion in the period under review, though commentators consistently identify a shortfall in late-stage growth capital as the principal constraint on scaling.
A Qualified Assessment
The European Innovation Scoreboard 2025 provides a useful corrective to an otherwise favourable reading of the UIBM data. Italy remains below the EU average on its Summary Innovation Index, with the most significant weaknesses concentrated in firm-level investment and access to finance, particularly among the micro-enterprises that constitute the bulk of the country’s economic structure. Italy performs above the EU average on the attractiveness of its research system and has recorded improvement in public R&D expenditure, but these strengths have not yet been matched by comparable private investment.
Conclusion
The 2025 data, read against its statutory and regulatory background, supports two conclusions. First, the 2023 Reform of Article 65 CPI and the parallel institutional support for technology transfer offices have had a measurable and attributable effect on filing volumes by universities and public research bodies. Second, the apparent decline in UIBM deposit and grant totals is not indicative of reduced innovative activity, but is properly explained by the jurisdictional reallocation of validation procedures to the EU Unitary Patent system and by ordinary prosecution timelines. The principal constraint on converting Italy’s patent and research output into commercial scale remains, on the available evidence, the availability of private growth capital rather than any deficiency in the underlying legal framework for protecting innovation.
